ANTIBIOTICE
84 articole · RSS
Antibiotice Celebrates 25 Years Since Its Listing On Bucharest Stock Exchange
Antibiotice (ATB), one of the most important Romanian generic drug producers, celebrates 25 years since its listing on the Bucharest Stock Exchange (BVB). The company’s shares have been trad...
Antibiotice Iasi Aims for EUR1B Turnover by 2030
Antibiotice Iasi, the biggest local Romanian-held drug maker, targets RON1 billion turnover by 2030, in line with its multi-annual plan, with half of this sum due to be generated by exports.
SIF Oltenia Buys RON855,200 Worth of Antibiotice Shares
Antibiotice Iasi (ATB.RO), the largest Romanian-owned pharmaceutical company, on Friday notified the Bucharest Stock Exchange that regional investment fund SIF Oltenia (SIF5.RO) bought 1.5 m...
Antibiotice Iasi Posts 21% Increase in Revenue to RON245M in Jan-Sep
The revenue of pharmaceutical company Antibiotice Iasi stood at RON245 million in January-September, an increase of 21% on the year-ago period, its report to the Bucharest Stock Exchange sho...
SIF Oltenia Buys 2.7% In Antibiotice Iasi for RON10.6M
Antibiotice Iasi (ATB.RO), the largest Romanian-held drug maker, on Friday reported on the Bucharest Stock Exchange that regional investment fund SIF Oltenia (SIF5) bought 18 million of its...
Antibiotice Iasi Earmarks RON93M for Investments in 2021
Pharmaceutical producer Antibiotice budgeted RON93 million investments for 2021, RON10 million more than in 2020, mainly to develop new facilities at its plant in Iasi.
Antibiotice Iasi Expects 7.5% Growth in Revenue to RON366M in 2021
Antibiotice Iasi (ATB.RO), the largest Romanian-held pharmaceutical producer, has budgeted RON366.5 million revenue for 2021, an increase of 7.5% on 2020, as shown in its spending and revenu...
Antibiotice Iasi To Provide Antibiotic Used in Covid Treatment to EU
Antibiotice Iasi (ATB.RO), the largest pharmaceutical producer in Romania, has won a tender held by the European Commission to supply necessary stock for the second wave of the Covid pandemi...
Antibiotice Iasi Sales Up Driven By 30% Higher Demand Compared With Previous Months
Antibiotice Iasi, the largest pharmaceutical producer in Romania, has seen sales up lately, as demand for medicines increased 30%, company CEO Ioan Nani says.